TimentinCompany: SmithKline Beecham
Approval Status: Approved January 1998
Treatment for: Infections in children
Areas: Immune System; Pediatrics
Possible similar drugs: Timentin
Timentin (disodium/clavulanate potassium) has been approved as an injectable antibiotic for use in treating a wide range of infections in children aged 3 months to 16 years. The drug was previously approved for use in adult patients.
Timentin Drug Information
The Timentin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.